Codrituzumab (Synonyms: GC33; RO5137382) |
| Catalog No.GC68889 |
Codrituzumab is a monoclonal antibody that targets GPC3 (glypican-3). GPC3 is an oncofetal protein expressed on the surface of hepatocellular carcinoma (HCC) cells. Codrituzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) and inhibits tumor growth.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1365267-33-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Codrituzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Codrituzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *